3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
1
Hepatitis
1
Colitis
1
Interventions
Specimen Handling
63
Magnetic Resonance Spectroscopy
43
Carboplatin
34
Cyclophosphamide
31
Gemcitabine
29
Cisplatin
27
Biopsy
27
pembrolizumab
26
Radiotherapy
26
Bevacizumab
25
Paclitaxel
23
Oxaliplatin
22
Standard of Care
21
Injections
21
Drug Therapy
21
Capecitabine
21
venetoclax
20
fludarabine
20
Nivolumab
20
Interviews as Topic
18
toripalimab
17
Radiosurgery
16
Dexamethasone
16
Blood Specimen Collection
16
Azacitidine
15
tislelizumab
14
cemiplimab
13
anlotinib
13
Irinotecan
13
130-nm albumin-bound paclitaxel
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Azathioprine
×
90 days
×
Clear all
NCT07619898
2026-06-02
PHOENIX-ECP
Therakos LLC
Phase 2
Not yet recruiting
112 enrolled